Response of hematopoiesis to cyclophosphamide follows highly specific patterns in bone marrow and spleen

Journal of Hematotherapy and Stem Cell Research

Volumn 12, Issue 1, 2003, Pages 47-61

  Šefc, Luděk ^a   Pšenák, Oskar ^a   Sýkora, Viktor ^a   Šulc, Karel ^a   Nečas, Emanuel ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; FLT3 LIGAND; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; STEM CELL FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL PROLIFERATION; COLONY FORMING UNIT GM; COLONY FORMING UNIT S; CONTROLLED STUDY; ERYTHROID CELL; FEMALE; GENE EXPRESSION; GRANULOCYTE; GRANULOCYTE PRECURSOR; HEMATOPOIESIS; LEUKOCYTE; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGENERATION; SPLEEN; SPLENECTOMY;

ALDEHYDE DEHYDROGENASE; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL DIVISION; CELL NUCLEUS; CYCLOPHOSPHAMIDE; CYTOKINES; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTES; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PROTEIN SYNTHESIS INHIBITORS; RNA, MESSENGER; SPLEEN; STEM CELLS; THYMIDINE; TIME FACTORS;

EID: 0037293242     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581603321210136     Document Type: Article

References (35)

1. Nedas E, V Znojil, and L Šefc. (1990). Hematopoietic stem cells: spleen colony forming cells are normally actively proliferating. Cell Tissue Kinet 23:637-649.
2. Blackett NM and LE Botnick. (1981). A regulatory mechanism for the number of pluripotential haemopoietic progenitor cells in mice. Blood Cells 7:417-443.
3. Till JE and EA McCulloch. (1961). A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 14:213-222.
4. Znojil V and E Nečas. (1988). The spleen colony technique. I. Correction for the overlap effect and sources of error in CFU-s determination. Cell Tissue Kinet 21:65-72.
5. Becker AJ, EA McCulloch, L Siminovitch and JE Till. (1965). The effect of differing demands for blood cell production on DNA synthesis by hemopoietic colony-forming cells of mice. Blood 26:296-308.
6. Domeyer BE and NE Sladek. (1980). Kinetics of cyclophosphamide biotransformation in vivo. Cancer Res 40:174-180.
7. Bagley CM, FW Bostick and VT DeVita Jr. (1973). Clinical pharmacology of cyclophosphamide. Cancer Res 33:226-233.
8. Bach JF and TB Strom, eds. (1985). The Mode of Action of Immunosuppressive Agents. Elsevier, Amsterdam, pp 175-239.
9. Kohn FR, GJ Landkammer, CL Manthey, NK Ramsay and NE Sladek. (1987). Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines. Cancer Res 47:3180-3185.
10. Valeriote FA, DC Collins and WR Bruce. (1968). Hematological recovery in the mouse following single dose of gamma radiation and cyclophosphamide. Radiat Res 33:501-511.
11. Fried W, S Husseini, S Gregory, WH Knospe and FE Trobaugh Jr. (1973). Effect of cyclophosphamide on the hematopoietic microenvironmental factors which influence hematopoietic stem cell proliferation. Cell Tissue Kinet 6:155-163.
12. Chervenick PA, DR Boggs, JC Marsh, GE Cartwright and MM Wintrobe. (1968). Quantitative studies of blood and bone marrow neutrophils in normal mice. Am J Physiol 215:353-359.
13. Novak JP and E Nečas. (1994). Proliferation-differentiation pathways of murine haemopoiesis: correlation of lineage fluxes. Cell Prolif 27:597-633.
14. Fazzi R, R Testi, S Trasciatti, S Galimberti, S Rosini, F Piras, G L'Abbate, A Conte and M Petrini (2002). Bone and bone-marrow interactions: haematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide. Mobilizing properties on white blood cells and peripheral blood stem cells in mice. Leuk Res 26:19-27.
15. Marsh JC. (1976). The effect of cancer chemotherapeutic agents on normal hematopoietic precursor cells: a review. Cancer Res 36:1853-1882.
16. de Jong JP, PGJ Nikkels, KGM Brockbank, RE Ploemacher and JSA Voerman. (1985). Comparative in vitro effects of cyclophosphamide derivates on murine bone marrow-derived stromal and hemopoietic progenitor cell classes. Cancer Res 45:4001-4005.
17. Blackett NM and M Aguado. (1979). The enhancement of haematopoietic stem cell recovery in irradiated mice by prior treatment with cyclophosphamide. Cell Tissue Kinet 12:291-298.
18. Botnick LE, EC Hannon, R Vigneulle and S Hellman. (1981). Differential effects of cytotoxic agents on hematopoietic progenitors. Cancer Res 41:2338-2342.
19. Marshall E, LB Woolford and BI Lord. (1997). Continuous infusion of macrophage inflammatory protein MIP-1alpha enhances leukocyte recovery and haemopoietic progenitor cell mobilization after cyclophosphamide. Br J Cancer 75:1715-1720.
20. Nečas E and V Znojil. (1987). CFU-S content and cycling rate in several strains of mice. Exp Hematol 15:759-764.
21. Nečas E, P Poňka and J Neuwirt. (1978). Changes in stem cell compartments in mice after hydroxyurea. Cell Tissue Kinet 11:119-127.
22. Nečas E, L Šefc and V Znojil. (1993). On control of the hematopoietic cell proliferation. Stem Cells 11:319-325.
23. Aguirre MV, JA Juaristi, M Alba Alvarez, RJ Carmuega and NC Brandan. (1999). [In vitro and in vivo studies of murine erythropoietic recovery after treatment with cyclophosphamide]. Sangre (Barc). 44:182-187.
24. Sladek NE. (1999). Aldehyde dehydrogenase-mediated cellular relative insensitivity to the oxazaphosphorines. Curr Pharm Ds 5:607-625.
25. Broudy VC. (1997). Stem cell factor and hematopoiesis. Blood 90:1345-1364.
26. Owen-Lynch PJ, LG Czaplewski, MG Hunter and AD Whetton. (1998). The growth inhibitory role and potential clinical value of macrophage inflammatory protein 1 alpha in myeloid leukaemias. Leuk Lymphoma 30:41-53.
27. Lyman SD and SEW Jacobsen. (1998). c-kit ligand and flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood 91:1101-1134.
28. Robinson S, RL Mosley, P Parajuli, V Pisarev, J Sublet, A Ulrich and J Talmadge. (2000). Comparison of the hematopoietic activity of flt-3 ligand and granulocyte-macrophage colony-stimulating factor acting alone or in combination. J Hematother Stem Cell Res 9:711-720.
29. de Vries P and JW Singer. (2000). Lisofylline suppresses ex vivo release by murine spleen cells of hematopoietic inhibitors induced by cancer chemotherapeutic agents. Exp Hematol 28:916-923.
30. Fleming WH, EJ Alpern, N Uchida, K Ikuta and IL Weissman. (1993). Steel factor influences the distribution and activity of murine hematopoietic stem cells in vivo. Proc Natl Acad Sci USA 90:3760-3764.
31. Molineux G, C McCrea, XQ Yan, P Kerzic and I McNiece. (1997). Flt-3 ligand synergizes with granulocyte colonystimulating factor to increase neutrophil numbers and to mobilize peripheral blood stem cells with long-term repopulating potential. Blood 89:3998-4004.
32. Ashihara E, C Shimazaki, Y Sudo, T Kikuta, H Hirai, T Sumikuma, A Yamagata, H Goto, T Inaba, A Fujita and M Nakagawa. (1998). FLT-3 ligand mobilizes hematopoietic primitive and committed progenitor cells into blood in mice. Eur J Haematol 60:86-92.
33. Broudy VC, NL Lin, GV Priestley, K Nocka and NS Wolf. (1996). Interaction of stem cell factor and its receptor c-kit mediates lodgment and acute expansion of hematopoietic cells in the murine spleen. Blood 88:75-81.
34. Mitruka BM, HM Rawnsley and BV Vadehra, eds. (1977). Clinical Biochemical and Hematological Reference Values in Normal Experimental Animals. Masson Publ Inc., New York, p 72.
35. Russel SE and SE Bernstein. (1966). Blood and blood formation. In: Biology of the Laboratory Mouse, 2nd ed. EL Green, ed. McGraw-Hill Book Company, New York, p 351.